Delivery Order SPE2DB22D2009-SPE2DB25FL9AA

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,492.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,439.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,956,585 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules, in 100-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 17, 2025. This award is not a...
This federal contract award, valued at $1,038.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,047.72, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) within the Department of Defense (DoD). The award was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of 20 mg capsules of the prescription drug dextroamphetamine-amphetamine, with an ultimate completion date of May 15, 2024. This is a delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,479.10, is for the delivery of 4,568,033,530 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $1,506.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FYAH3) for the supply of 4,568,055,092 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,058.45 firm fixed-price delivery order is for 100 capsules of the prescription drug dextroamphetamine-amphetamine 20 mg. The contract has an ultimate completion date of April 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
This federal contract award, valued at $1,260.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,334,653 units of dextroamphetamine-amphetamine 15 mg capsules, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,237.89, is a Firm Fixed Price Delivery Order to provide 4,567,886,472 units of the prescription drug dextroamphetamine-amphetamine 10 mg capsules. The award has an ultimate completion date of April 14, 2025. This contract is not associated with a set-aside designation. Amerisourcebergen holds a...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $1,761.89 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,560,135,898 units of the medication dextroamphetamine-amphetamine 20 mg capsules. The contract has an ultimate completion date of March 2, 2023 and was awarded on March 1, 2023. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL9AA
    Delivery Order

This federal contract award, valued at $2,373.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,076,029 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The present award is not designated as a set-aside contract.

Generated 7/29/25, 10:02 AM